Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-25-064283
Filing Date
2025-07-15
Accepted
2025-07-15 16:30:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 7793
  Complete submission text file 0001213900-25-064283.txt   9511
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Subject) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-84759 | Film No.: 251125129
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1197 LA PLURISSIMA PL FREMONT CA 94539
Business Address
Jiang Eugene (Filed by) CIK: 0001892728 (see all company filings)

Type: SCHEDULE 13D/A